高级检索

    脑脊液VDBP、Tenascin-C在儿童急性细菌性脑膜炎中的表达及临床意义

    Expression and clinical significance of cerebrospinal fluid VDBP and Tenascin-C in children with acute bacterial meningitis

    • 摘要: 目的 探讨脑脊液维生素D结合蛋白(VDBP)和肌腱蛋白-C(Tenascin-C)在儿童急性细菌性脑膜炎(ABM)中的表达及临床意义。方法 选取2021年1月—2024年10月西安交通大学第一附属医院榆林医院儿科收治的ABM患儿150例。根据住院期间是否发生并发症分为并发症组和无并发症组,根据出院时预后情况分为不良预后组和良好预后组。采用酶联免疫吸附试验检测脑脊液VDBP和Tenascin-C水平。通过多因素非条件logistic回归分析脑脊液VDBP、Tenascin-C水平与ABM患儿不良预后的关系;绘制受试者工作特征(ROC)曲线分析脑脊液VDBP、Tenascin-C水平对ABM患儿并发症发生及不良预后的预测价值。结果 150例ABM患儿中57例发生并发症,并发症发生率为38.00%(57/150)。与无并发症组比较,并发症组患儿脑脊液VDBP和Tenascin-C水平均明显升高(P<0.05)。脑脊液VDBP与Tenascin-C联合预测ABM患儿并发症的曲线下面积(AUC)为0.873,高于VDBP和Tenascin-C单独预测的0.788和0.798(P<0.05)。与良好预后组比较,不良预后组患儿脑脊液VDBP和Tenascin-C水平均明显升高(P<0.05)。多因素logistic回归分析显示,反复惊厥发作、并发症发生、脑脊液葡萄糖与血糖比值降低、VDBP水平升高及Tenascin-C水平升高均为ABM患儿不良预后的独立危险因素(P<0.05)。脑脊液VDBP与Tenascin-C联合预测ABM患儿不良预后的AUC为0.900,高于VDBP和Tenascin-C单独预测的0.806和0.817(P<0.05)。结论 脑脊液VDBP和Tenascin-C水平升高与ABM患儿并发症发生及不良预后密切相关,二者联合检测对ABM患儿并发症发生及不良预后的预测具有较高价值。

       

      Abstract: Objective To investigate the expression of cerebrospinal fluid vitamin D binding protein (VDBP) and Tenascin-C in children with acute bacterial meningitis (ABM) and its clinical significance. Methods A total of 150 ABM children who were admitted to Department of Pediatrics, Yulin Hospital, the First Affiliated Hospital of Xi'an Jiaotong University, from January 2021 to October 2024 were enrolled. According to whether complications occurred during hospitalization, the patients were divided into a complication group and a non-complication group. According to the prognosis at discharge, the patients were again divided into a poor prognosis group and a good prognosis group. Enzyme-linked immunosorbent assay (ELISA) was used to detect the levels of VDBP and Tenascin-C in cerebrospinal fluid. Multivariate unconditional logistic regression analysis was performed to evaluate the relationship between cerebrospinal fluid VDBP and Tenascin-C levels and poor prognosis in children with ABM. Receiver operating characteristic (ROC) curves were plotted to assess the predictive value of cerebrospinal fluid VDBP and Tenascin-C levels for complications and poor prognosis in children with ABM. Results Among the 150 children with ABM, 57 developed complications, with an incidence of 38.00% (57/150). Compared with the non-complication group, the levels of cerebrospinal fluid VDBP and Tenascin-C were significantly increased in the complication group (P<0.05). The area under the ROC curve (AUC) for the combined prediction of complications using cerebrospinal fluid VDBP and Tenascin-C was 0.873, which was higher than that of VDBP (0.788) or Tenascin-C (0.798) alone (P<0.05). Compared with the good prognosis group, the levels of cerebrospinal fluid VDBP and Tenascin-C were significantly increased in the poor prognosis group (P<0.05). Multivariate logistic regression analysis showed that recurrent seizures, presence of complications, reduced cerebrospinal fluid glucose/blood glucose ratio, increased VDBP levels, and increased Tenascin-C levels were independent risk factors for poor prognosis in children with ABM (P<0.05). The AUC for the combined prediction of poor prognosis using cerebrospinal fluid VDBP and Tenascin-C was 0.900, which was higher than that of VDBP (0.806) or Tenascin-C (0.817) alone (P<0.05). Conclusions Elevated levels of cerebrospinal fluid VDBP and Tenascin-C are closely associated with the occurrence of complications and poor prognosis in children with ABM. The combined detection of VDBP and Tenascin-C has a high predictive value for complications and poor prognosis in children with ABM.

       

    /

    返回文章
    返回